Clinical Trials for Ovarian Cancer

Clinical trials are research studies conducted in an effort to improve overall patient health and care. Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition. Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks. A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.

A brief description of each phase:

Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
Phase IV: These studies monitor long-term side effects after the treatment has been marketed.

Clinical Trials data for Ovarian Cancer is grouped into the following categories:-

View by trial name

View by drugs used in Ovarian Cancer clinical trials

Clinical Trials by trial name

The format for each of the following is:

The name of the trial,
followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
followed by a list of drug/s, if any, used in the trial

ClinicalTrials.gov has listed the following trials for Ovarian Cancer:

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies - This study is no longer recruiting patients (Current: 23 Nov 2006) - Aroplatin (Liposomal NDDP, L-NDDP)
OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206 - This study is no longer recruiting patients (Current: 23 Nov 2006) - Neoadjuvant chemotherapy (Paclitaxel and Carboplatin)
Safety and Efficacy Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - catumaxomab
ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - SH-Y03757A (ZK-Epothilone; ZK-219477) with carboplatin
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - AVE0005 (VEGF Trap)
A Safety and Tolerability Study of Oral TAK-165 Administered to Subjects With Tumors Known to Express HER2 - This study is no longer recruiting patients (Current: 23 Nov 2006) - TAK-165
Contrast-Enhanced Ultrasound Ability in the Characterization of Ovarian Masses - This study is currently recruiting patients (Current: 23 Nov 2006)
A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients - This study has been completed (Current: 23 Nov 2006)
A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin - This study has been completed (Current: 23 Nov 2006)
Outcomes of Education and Counseling for BRCA1 Testing - This study has been completed (Current: 23 Nov 2006)
A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients with Ovarian Epithelial Carcinoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - oregovomab
Tandem Cycles of High Dose Chemotherapy Followed by Stem Cell Support for Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - induction chemo and G-CSF,Paclitaxel/Carboplatin,Topotecan/Etopophos,Thiotepa therapy
Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-chemotherapy Consolidation for Ovarian Carcinoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - oregovomab
EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - epothilone b
Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - TLK286
Massage Therapy for Cancer-Related Fatigue - This study has been completed (Current: 23 Nov 2006)
Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer. - This study is no longer recruiting patients (Current: 23 Nov 2006) - intravenous T900607-sodium
Study of OSI-211 Vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer - This study has been completed (Current: 23 Nov 2006) - OSI-211 (Liposomal Lurtotecan)
Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian Cancer - This study has been terminated (Current: 23 Nov 2006) - SGN-15 (cBR96-Doxorubicin Immunoconjugate),Gemzar (Gemcitabine)
TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - TLK286
TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - TLK286
TLK286 (Telcyta) Vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - TLK286 HCl for injection,topotecan hydrochloride for injection,doxorubicin HCl liposome injection
Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer - This study has been completed (Current: 23 Nov 2006) - Investigational New Drug
Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - Motexafin Gadolinium Injection
Acupuncture for Women's Health Conditions - This study is currently recruiting patients (Current: 23 Nov 2006)
TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - TLK286 (Telcyta) HCI for Injection,Carboplatin, Paraplatin for Injection,Doxorubicin HCI Liposome Injection
Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy - This study is currently recruiting patients (Current: 23 Nov 2006) - Pemetrexed
Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - Motexafin Gadolinium
Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence - This study is currently recruiting patients (Current: 23 Nov 2006)
Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients - This study is currently recruiting patients (Current: 23 Nov 2006) - Avastin
Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - bevacizumab,erlotinib
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation - This study is currently recruiting patients (Current: 23 Nov 2006)
Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms - This study is currently recruiting patients (Current: 23 Nov 2006)
Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers - This study is currently recruiting patients (Current: 23 Nov 2006) - Doxil,5FU
A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer. - This study has been completed (Current: 23 Nov 2006) - Gemcitabine,liposomal doxorubicin
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy - This study is currently recruiting patients (Current: 23 Nov 2006) - Gemcitabine,paclitaxel,carboplatin
Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-Line or Later Therapy in Patients With Mllerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Platinum-Based Chemotherapy - This study is no longer recruiting patients (Current: 23 Nov 2006) - doxorubicin hydrochloride
Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers - This study is currently recruiting patients (Current: 23 Nov 2006) - Topotecan and Taxotere
Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis - This study is currently recruiting patients (Current: 23 Nov 2006) - Chemotherapeutic Agent
Efficacy and Safety Study of ZK219477 in Patients With Recurrent Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - ZK 219477
Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
Study of Pemetrexed in Lung and Ovarian Cancer Patients With Fluid Around the Lungs or Abdomen - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - pemetrexed
Ph 3 Randomized Study of Telcyta + Liposomal Doxorubicin Vs Liposomal Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - TLK286 (Telcyta) HCI for Injection,Doxorubicin HCI Liposome Injection
Questionnaire Study for Gynecological Cancer Survivors - This study is currently recruiting patients (Current: 23 Nov 2006)
AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites - This study is currently recruiting patients (Current: 23 Nov 2006) - AVE0005 (VEGF Trap)
Microarray Analysis for Human Genetic Disease - This study is no longer recruiting patients (Current: 23 Nov 2006)
Phase II CT-2103/Carboplatin in Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - CT-2103 (poly(L)glutamate-paclitaxel),carboplatin
DOXIL for Consolidation Therapy in Ovarian Cancer. - This study is currently recruiting patients (Current: 23 Nov 2006) - liposomal doxorubicin
Trial of Tri-Weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - Paclitaxel 180mg/m2＋CBDCA AUC6 q21 days x 6-9cycles,Paclitaxel 80mg/m2 weekly ＋CBDCA AUC6 q21 days x 6-9cycles
Risk of Ovarian Cancer in Patients With a Pelvic Mass - This study is currently recruiting patients (Current: 23 Nov 2006)
Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer - This study has been completed (Current: 23 Nov 2006) - Paclitaxel,Carboplatin
A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 - This study has been completed (Current: 23 Nov 2006) - PSC 833
A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 - This study has been completed (Current: 23 Nov 2006)
Vinorelbine and XR9576 to Treat Cancer - This study has been completed (Current: 23 Nov 2006)
Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,cisplatin,cyclophosphamide,doxorubicin
Combination Chemotherapy in Treating Children With Non-Testicular Malignant Germ Cell Tumors - This study has been completed (Current: 23 Nov 2006) - carboplatin,cyclophosphamide,dactinomycin,doxorubicin,etoposide,filgrastim,leucovorin calcium,methotrexate,vincristine
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,doxorubicin
Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,etoposide
Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers - This study is no longer recruiting patients (Current: 23 Nov 2006)
Screening for Cancer of the Prostate, Lung, Colon, Rectum, or Ovaries in Older Patients - This study is no longer recruiting patients (Current: 23 Nov 2006)
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,etoposide,filgrastim,ifosfamide,paclitaxel
Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,filgrastim,ifosfamide,paclitaxel
Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,paclitaxel
Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer - This study has been completed (Current: 23 Nov 2006) - carboplatin,cyclophosphamide,filgrastim
Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,paclitaxel
Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer - This study has been completed (Current: 23 Nov 2006) - carboplatin,cyclophosphamide,mitoxantrone,paclitaxel
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function - This study is no longer recruiting patients (Current: 23 Nov 2006) - docetaxel
Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - docetaxel
Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,filgrastim,paclitaxel,topotecan
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,etoposide,filgrastim,ifosfamide,paclitaxel
Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer - This study has been suspended (Current: 23 Nov 2006) - carboplatin,cyclophosphamide,etoposide
Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission - This study is no longer recruiting patients (Current: 23 Nov 2006) - filgrastim,melphalan,thiotepa
HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-Small Cell Lung Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - HER-2/neu peptide vaccine,sargramostim
Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-Small Cell Lung Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - amifostine,carboplatin,paclitaxel
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer - This study has been completed (Current: 23 Nov 2006) - melphalan,mitoxantrone,tamoxifen,thiotepa
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors - This study has been completed (Current: 23 Nov 2006) - interleukin-12
Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission - This study is no longer recruiting patients (Current: 23 Nov 2006) - paclitaxel
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - doxorubicin HCl liposome,fluorouracil
Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum - This study is no longer recruiting patients (Current: 23 Nov 2006) - paclitaxel
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - glutamine
Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,cisplatin,cyclophosphamide,doxorubicin,paclitaxel
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - amifostine,cisplatin,cyclophosphamide,etoposide,sargramostim
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - mitoxantrone,thiotepa,topotecan
Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,paclitaxel
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract - This study has been completed (Current: 23 Nov 2006) - doxorubicin HCl liposome,paclitaxel
Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,irinotecan
Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,gemcitabine
Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,gemcitabine,paclitaxel
Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer - This study has been completed (Current: 23 Nov 2006) - doxorubicin HCl liposome,etoposide
Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - filgrastim,gemcitabine,topotecan
Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,doxorubicin HCl liposome,paclitaxel
Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer - This study has been completed (Current: 23 Nov 2006) - BCG,carboplatin,cisplatin,cyclophosphamide,dinitrophenyl,paclitaxel
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - interferon alfa,interleukin-2,sargramostim
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carmustine,cisplatin,filgrastim,melphalan,paclitaxel
High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation and Chemoprotective Therapy in Treating Patients With Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - amifostine,cyclophosphamide,filgrastim,melphalan
Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer - This study has been completed (Current: 23 Nov 2006) - interleukin-12
Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - gemcitabine,paclitaxel
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - antineoplaston A10,antineoplaston AS2-1
Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,docetaxel
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer - This study has been completed (Current: 23 Nov 2006) - amifostine,cisplatin,paclitaxel
Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy - This study is no longer recruiting patients (Current: 23 Nov 2006) - monoclonal antibody B43.13
Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,cisplatin
Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,paclitaxel
Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,paclitaxel,topotecan hydrochloride
Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,paclitaxel,topotecan
Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer - This study has been completed (Current: 23 Nov 2006) - folic acid
Quality-of-Life Assessment in Patients With Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer - This study has been completed (Current: 23 Nov 2006)
Quality of Life in Survivors of Gynecologic Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - chemoprotection,amifostine,bleomycin,cisplatin,etoposide
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - bone marrow ablation with stem cell support,carboplatin,cyclophosphamide,epirubicin,etoposide,filgrastim,ifosfamide,paclitaxel,thiotepa
Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer - This study has been completed (Current: 23 Nov 2006) - carboplatin,paclitaxel,SCH-58500
Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation - This study is no longer recruiting patients (Current: 23 Nov 2006) - fluconazole,itraconazole
Combination Chemotherapy in Treating Women With Stage III Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,doxorubicin HCl liposome,paclitaxel
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,cyclophosphamide,filgrastim,paclitaxel,topotecan
Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - etoposide,topotecan
Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,docetaxel,paclitaxel
Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer - This study has been completed (Current: 23 Nov 2006) - bryostatin 1
Biological Therapy Following Surgery and Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - autologous tumor cell vaccine,interleukin-2,interleukin-2/monoclonal antibody OKT3,monoclonal antibody OKT3,sargramostim
Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer - This study has been completed (Current: 23 Nov 2006) - DX-8951f
Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - monoclonal antibody B43.13
Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,docetaxel,gemcitabine
Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy - This study is no longer recruiting patients (Current: 23 Nov 2006) - yttrium Y 90 monoclonal antibody HMFG1
Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - filgrastim,interleukin-11
Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy - This study is no longer recruiting patients (Current: 23 Nov 2006) - amifostine
Gene Therapy in Treating Patients With Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - bone marrow ablation with stem cell support,carboplatin,cyclophosphamide,filgrastim,paclitaxel,topotecan
Biological Therapy in Treating Patients With Metastatic Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carcinoembryonic antigen RNA-pulsed DC cancer vaccine
Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,thalidomide
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery - This study has been completed (Current: 23 Nov 2006) - octreotide
High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,cyclophosphamide,filgrastim,melphalan,paclitaxel
Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer - This study has been completed (Current: 23 Nov 2006) - carboplatin,epirubicin,paclitaxel
Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer - This study has been completed (Current: 23 Nov 2006) - HER-2-neu peptide vaccine,sargramostim
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,paclitaxel,topotecan
Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer - This study has been completed (Current: 23 Nov 2006) - carboplatin,cisplatin,paclitaxel,topotecan
Ovarian Cancer Early Detection Program Screening and Genetic Study - This study is currently recruiting patients (Current: 23 Nov 2006)
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,cyclophosphamide,etoposide,filgrastim,paclitaxel,topotecan
ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment - This study is no longer recruiting patients (Current: 23 Nov 2006) - ILX-295501
LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-Small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer - This study has been completed (Current: 23 Nov 2006) - LMB-9 immunotoxin
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum - This study has been completed (Current: 23 Nov 2006) - floxuridine,leucovorin calcium,oxaliplatin
Biological Therapy in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - autologous dendritic cells,HER-2/neu intracellular domain protein
Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,doxorubicin,filgrastim,paclitaxel,pegfilgrastim
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,lurtotecan liposome
Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin - This study is no longer recruiting patients (Current: 23 Nov 2006) - temozolomide
Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer - This study has been completed (Current: 23 Nov 2006) - indium In 111 monoclonal antibody Hu3S193
SU5416 and Carboplatin to Treat Ovarian Cancer - This study has been completed (Current: 23 Nov 2006)
Paclitaxel in Treating Patients With Ovarian Stromal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - paclitaxel
Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - nitrocamptothecin
Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - This study has been completed (Current: 23 Nov 2006) - carboplatin,doxorubicin HCl liposome
Chemotherapy, Radiation Therapy, Peripheral Stem Cell Transplantation, and Immunosuppressive Therapy in Treating Patients With Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - allogeneic lymphocytes,cyclosporine,fludarabine,mycophenolate mofetil
Conventional Care With or Without Specialized Cancer Care in Treating Patients Receiving Chemotherapy - This study is no longer recruiting patients (Current: 23 Nov 2006)
Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer - This study has been completed (Current: 23 Nov 2006) - rebeccamycin analogue
Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,paclitaxel,topotecan
Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - bryostatin 1,cisplatin
Combination Chemotherapy and Surgery in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,paclitaxel
Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment - This study is no longer recruiting patients (Current: 23 Nov 2006) - infection prophylaxis/management,amphotericin B liposomal,caspofungin acetate
Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - lurtotecan liposome
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon - This study is no longer recruiting patients (Current: 23 Nov 2006) - beclomethasone
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,doxorubicin HCl liposome,gemcitabine,paclitaxel,topotecan
Comparison of Antibody Therapies in Treating Patients With Graft- Versus-Host Disease That Does Not Respond to Steroid Therapy - This study is no longer recruiting patients (Current: 23 Nov 2006) - anti-thymocyte globulin,monoclonal antibody ABX-CBL
Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation - This study is no longer recruiting patients (Current: 23 Nov 2006) - palivizumab,ribavirin
Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk - This study is currently recruiting patients (Current: 23 Nov 2006) - fenretinide
Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,IM-862,paclitaxel
Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - MVF-HER-2(628-647)-CRL 1005 vaccine
Combination Chemotherapy in Treating Patients With Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,cyclophosphamide,filgrastim,paclitaxel
Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer - This study has been completed (Current: 23 Nov 2006) - interleukin-2,mutant p53 peptide pulsed dendritic cell vaccine,ras peptide cancer vaccine,sargramostim
Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer - This study has been completed (Current: 23 Nov 2006) - irofulven
p53 Vaccine in Treating Patients With Adenocarcinoma of the Ovary Who Have Either No Evidence of Disease or Elevated Biomarkers - This study is no longer recruiting patients (Current: 23 Nov 2006) - Montanide ISA-51,autologous dendritic cells,interleukin-2,p53 peptide vaccine,sargramostim
Protein Evaluation in Patients With Stage III or Stage IV Primary Peritoneal or Fallopian Tube Cancer or Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer in Remission - This study is no longer recruiting patients (Current: 23 Nov 2006)
Tariquidar Plus Chemotherapy in Treating Children With Relapsed or Refractory Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - docetaxel,doxorubicin hydrochloride,filgrastim,tariquidar,vinorelbine ditartrate
Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer or Other Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - aldesleukin,busulfan,carboplatin,cyclophosphamide,etoposide,filgrastim,ifosfamide,paclitaxel,sargramostim,therapeutic autologous lymphocytes
Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - taurolidine
Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,squalamine lactate
TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - TLK286
Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - EGFR antisense DNA,keyhole limpet hemocyanin,sargramostim
Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - arsenic trioxide
Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - thalidomide
Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,cisplatin,paclitaxel,topotecan hydrochloride
Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - ixabepilone
Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,gemcitabine,paclitaxel
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,doxorubicin HCl liposome
Screening Women at High Genetic Risk for Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - S-8184 Paclitaxel Injectable Emulsion
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation - This study is currently recruiting patients (Current: 23 Nov 2006)
Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - imatinib mesylate
ABT-751 in Treating Young Patients With Refractory Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - ABT-751
Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - ipilimumab
Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
Study of Individuals and Families at High Risk for Testicular Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, or Germ Cell Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - tamoxifen citrate,thalidomide
Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer - This study has been completed (Current: 23 Nov 2006) - imatinib mesylate
Carboplatin With or Without Liposomal Doxorubicin in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,pegylated doxorubicin HCl liposome
Study of Individuals and Families at High Risk for Breast or Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,ifosfamide
Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer - This study has been terminated (Current: 23 Nov 2006) - Interferon gamma-1b
Screening Study of Surgery and CA 125 Levels in Participants at Increased Genetic Risk of Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
Phase 2 Study of ET-743 in Subjects With Advanced Ovarian Cancer - This study has been completed (Current: 23 Nov 2006) - ET-743
Clinical Trial for Ovarian Cancer (OvaRex) - This study is currently recruiting patients (Current: 23 Nov 2006) - oregovomab
Carboplatin and Paclitaxel With or Without Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,gemcitabine,paclitaxel
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors - This study has been suspended (Current: 23 Nov 2006) - bleomycin,cisplatin,etoposide
Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - irofulven
Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - irinotecan
Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer - This study has been suspended (Current: 23 Nov 2006) - Gemzar and Alimta
Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - topotecan hydrochloride
CA 125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women - This study is no longer recruiting patients (Current: 23 Nov 2006)
Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - monoclonal antibody ACA125 anti-idiotype vaccine
A Study to Evaluate the Effect of HER2 Activation on rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - Pertuzumab (rhuMAb 2C4)
PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - PS-341 and Carboplatin
Combination Chemotherapy Plus Erlotinib in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,erlotinib hydrochloride,paclitaxel
Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,paclitaxel poliglumex
Monoclonal Antibody Therapy After Allogeneic Stem Cell Transplantation in Treating Patients With Persistent or Progressive Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - allogeneic lymphocytes,ipilimumab
Second-Line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer - This study has been terminated (Current: 23 Nov 2006) - Topotecan,Gemcitabine
Phase II Study in Patients With EGFR + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - Cetuximab
Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - docetaxel
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors - This study has been completed (Current: 23 Nov 2006) - SS1(dsFv)-PE38 immunotoxin
Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - Montanide ISA-51,NY-ESO-1 peptide vaccine
Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Allogeneic Transplantation - This study is currently recruiting patients (Current: 23 Nov 2006) - allogeneic lymphocytes
Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - ixabepilone
Acupuncture to Improve Quality of Life in Patients With Advanced Cancer - This study has been completed (Current: 23 Nov 2006)
Tariquidar and Docetaxel in Treating Patients With Recurrent or Metastatic Lung, Ovarian, or Cervical Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - docetaxel,tariquidar
UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer - This study has been suspended (Current: 23 Nov 2006) - UCN-01,topotecan
Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer - This study has been completed (Current: 23 Nov 2006) - yttrium Y 90 monoclonal antibody Hu3S193
A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer - This study has been completed (Current: 23 Nov 2006) - EMD 72000
Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - pentostatin
Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - docetaxel,oxaliplatin
Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,paclitaxel
Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - amifostine trihydrate
Adjuvant Intraperitoneal Carboplatin With Paclitaxel in Treating Patients Who Had Initial Debulking Surgery for Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer - This study has been suspended (Current: 23 Nov 2006) - carboplatin,paclitaxel
CA-125 in Screening Patients at High Risk for Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - 3-AP,cisplatin
A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma - This study has been suspended (Current: 23 Nov 2006) - Cetuximab
Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - cisplatin,flavopiridol
Efficacy of 6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels - This study is currently recruiting patients (Current: 23 Nov 2006) - Å6 subcutaneous injection
Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy - This study is no longer recruiting patients (Current: 23 Nov 2006) - celecoxib
Carboplatin Plus Docetaxel and Paclitaxel in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,docetaxel,paclitaxel
FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer - This study has been completed (Current: 23 Nov 2006) - FR901228
Study of Ovarex (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment - This study is no longer recruiting patients (Current: 23 Nov 2006) - oregovomab
Immunosuppressive Treatment Regimens With or Without Mycophenolate Mofetil in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - cyclosporine,mycophenolate mofetil,prednisone,sirolimus,tacrolimus
17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - 17-dimethylaminoethylamino-17-demethoxygeldanamycin
Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - Taxotere®,Carboplatin
Vaccine Therapy and Sargramostim in Treating Adults With Metastatic Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - recombinant fowlpox-CEA-MUC-1-TRICOM vaccine,recombinant vaccinia-CEA(D609)/MUC1(L93)/TRICOM vaccine,sargramostim
Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - Montanide ISA-51,ovarian cancer peptide vaccine,sargramostim,tetanus toxoid helper peptide
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer - This study has been suspended (Current: 23 Nov 2006) - 17-N-allylamino-17-demethoxygeldanamycin
Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer - This study has been suspended (Current: 23 Nov 2006) - sorafenib
Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - celecoxib
Pentostatin and Donor White Blood Cells in Preventing Graft Rejection in Cancer Patients Who Have Undergone Donor Stem Cell Transplantation - This study is currently recruiting patients (Current: 23 Nov 2006) - allogeneic lymphocytes,cyclosporine,mycophenolate mofetil,pentostatin
Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,paclitaxel,sorafenib
A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - rhuMAb 2C4 (pertuzumab)
A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed - This study is no longer recruiting patients (Current: 23 Nov 2006) - bevacizumab
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - Ispinesib
Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries - This study is currently recruiting patients (Current: 23 Nov 2006) - fenretinide
Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin
Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - therapeutic autologous lymphocytes
Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Subjects With Advanced Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - AMG 706,Panitumumab
Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer - This study has been completed (Current: 23 Nov 2006) - Topotecan
Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer - This study has been completed (Current: 23 Nov 2006) - Gemcitabine
Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - intraperitoneal tgDCC-E1A + intravenous paclitaxel,intravenous paclitaxel alone
Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response - This study has been completed (Current: 23 Nov 2006)
EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer - This study has been completed (Current: 23 Nov 2006) - EF5
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - paclitaxel,paclitaxel poliglumex
Alemtuzumab, Tacrolimus, and Methylprednisolone in Treating Acute Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant - This study is currently recruiting patients (Current: 23 Nov 2006) - alemtuzumab,methylprednisolone,tacrolimus
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant - This study is currently recruiting patients (Current: 23 Nov 2006) - caspofungin acetate
Vaccine Therapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - fowlpox-NY-ESO-1 vaccine,recombinant vaccinia-NY-ESO-1 vaccine
A Study Comparing the Combination of Doxil and Yondelis, to Doxil Alone for Subjects With Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - Yondelis,Doxil
Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - Pegfilgrastim
Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - topotecan hydrochloride
A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood - This study has been completed (Current: 23 Nov 2006) - pegfilgrastim,carboplatin,paclitaxel
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - capecitabine
Proteomic Profiling in Predicting Relapse in Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
Carboplatin Taxol Avastin in Ovarian Cancer (OVCA) - This study is currently recruiting patients (Current: 23 Nov 2006) - Taxol; Carboplatin; Bevacizumab
EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-Small Cell Lung Cancers When First Given Cyclophosphamide - This study is currently recruiting patients (Current: 23 Nov 2006) - EMD 273066
Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,docetaxel
IGFBP-3 in Ovarian Cancer Invasion - This study is currently recruiting patients (Current: 23 Nov 2006)
Mesothelin as a New Tumor Marker for Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
The Development of Human Immunologic Assays Specific to Folate Receptor Antigen - This study is currently recruiting patients (Current: 23 Nov 2006)
Biobank Ovary Carcinoma: Storing Blood and Protein of Patients With Ovary Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - Chemotherapy, multiple agents
GM-CSF in Women With Recurrent Ovary Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - GM-CSF, Leukine
Taxol Carboplatin and Erythropoetin - This study is no longer recruiting patients (Current: 23 Nov 2006) - Paclitaxel
Evaluating Tools for Health Promotion and Disease Prevention - This study is currently recruiting patients (Current: 23 Nov 2006)
Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing - This study is no longer recruiting patients (Current: 23 Nov 2006)
Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - Caelyx
Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-Resistant Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - Hycamtin
Preference Study With Elderly Patients Recurrent Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - Ovastat
PTEN and IGFBP-3 Correlation in Ovarian Carcinoma Invasion - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid CC-5013) With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - CC-5013,topotecan
Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma - This study has been terminated (Current: 23 Nov 2006) - CC-5013,liposomal doxorubicin
Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - Iressa (ZD1839),Arimidex (Anastrozole)
Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin - This study is currently recruiting patients (Current: 23 Nov 2006) - Paclitaxel,Carboplatin
Ixabepilone and Liposomal Doxorubicin in Treating Patients With Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer or Metastatic Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - ixabepilone,pegylated doxorubicin HCl liposome
Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma - This study is currently recruiting patients (Current: 23 Nov 2006) - Docetaxel and Gemcitabine
Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients - This study is no longer recruiting patients (Current: 23 Nov 2006)
A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-Based Therapy - This study has been completed (Current: 23 Nov 2006) - ZD1839,tamoxifen
Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse - This study is currently recruiting patients (Current: 23 Nov 2006) - Pegylated liposomal doxorubicin,Carboplatin,Paclitaxel
Taxol in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse - This study is currently recruiting patients (Current: 23 Nov 2006) - Paclitaxel,Topotecan,Carboplatin
Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - Herceptin
A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment - This study is no longer recruiting patients (Current: 23 Nov 2006) - arzoxifene
Gemcitabine in Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - Gemcitabine,Cisplatin
Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - Topotecan,Paclitaxel,Carboplatin
A Phase I Safety and Efficacy Trial of a DNA Plasmid Based Vaccine in Subjects With HER-2/Neu-Overexpressing Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
Weekly Topotecan Therapy in Patients With Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - Topotecan
Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - Carboplatin,Docetaxel
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer - This study has been terminated (Current: 23 Nov 2006) - Imatinib Mesylate,Docetaxel
Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,docetaxel,erlotinib hydrochloride,pegfilgrastim
Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,docetaxel,pegfilgrastim
Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - docetaxel,gemcitabine hydrochloride
Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants - This study is currently recruiting patients (Current: 23 Nov 2006)
A Phase I Study of Infusion of HER-2/Neu Specific T Cells in Patients With Advanced Stage HER-2/Neu Expressing Cancers Who Have Received a HER-2/Neu Vaccine - This study is currently recruiting patients (Current: 23 Nov 2006)
Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - Carboplatin,Pemetrexed (Alimta)
Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV - This study has been completed (Current: 23 Nov 2006) - Paraplatin,Paclitaxel
Denileukin Diftitox in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - denileukin diftitox
Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass - This study is currently recruiting patients (Current: 23 Nov 2006)
Fragmin in Ovarian Cancer: Utility on Survival (FOCUS) - This study is currently recruiting patients (Current: 23 Nov 2006) - dalteparin
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer, Metastatic Breast Cancer, or Advanced Endometrial Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - pyridoxine
Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma - This study is currently recruiting patients (Current: 23 Nov 2006) - sorafenib
Aprepitant, Ondansetron, and Dexamethasone in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant - This study is currently recruiting patients (Current: 23 Nov 2006) - aprepitant,dexamethasone,ondansetron
Clinical Benefit of Topoisomerase Downregulation - This study is currently recruiting patients (Current: 23 Nov 2006) - Topotecan and VP16
Positron Emission Tomography Using C Topotecan in Predicting Response to Treatment in Patients With Brain Metastases Due to Ovarian, Small Cell Lung, or Other Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - 11C topotecan,fludeoxyglucose F 18
Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - Exemestane
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - cisplatin,tirapazamine
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - bevacizumab,carboplatin,paclitaxel
Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - erlotinib hydrochloride
A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Ovarian Cancer Patients Who Develop Chemotherapy-Induced Peripheral Neuropathy - This study is currently recruiting patients (Current: 23 Nov 2006) - epoetin alfa
Ovarian Screening Study - This study is currently recruiting patients (Current: 23 Nov 2006)
Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - Bevacizumab (drug), Gemcitabine (drug) & Carboplatin (drug)
Study of ONTAK in Patients With Advanced Stage Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - denileukin diftitox (ONTAK)
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients - This study is currently recruiting patients (Current: 23 Nov 2006) - Docetaxel (Taxotere),PTK787
The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy - This study is no longer recruiting patients (Current: 23 Nov 2006) - epoetin alfa
Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - bleomycin,carboplatin,cisplatin,etoposide,ifosfamide,vinblastine
AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - AZD2171
Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - bleomycin,carboplatin,etoposide
Study of XL999 in Patients With Previously Treated Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - XL999
AZD2171 in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - AZD2171
Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-Line Treatment of Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - Lonafarnib
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - GW786034
Safety of Antioxidants During GYN Cancer Care - This study is currently recruiting patients (Current: 23 Nov 2006) - Intravenous vitamin C (ascorbic acid)
Ovarian Cancer Prevention - This study is currently recruiting patients (Current: 23 Nov 2006)
Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer. - This study is currently recruiting patients (Current: 23 Nov 2006) - Essiac
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - docetaxel
Accuracy of the ChemoFx Chemoresponse Assay in Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer. - This study is currently recruiting patients (Current: 23 Nov 2006)
Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers - This study is currently recruiting patients (Current: 23 Nov 2006) - CHP-HER2, CHP-NY-ESO-1
CT-2106 for the Second Line Treatment of Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - CT-2106
Hypnosis, Massage Therapy, and Healing Touch in Treating Patients Receiving Chemotherapy for Ovarian Epithelial Cancer or Peritoneal Cavity Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
Aprepitant, Granisetron, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Cyclophosphamide Before a Stem Cell Transplant - This study is currently recruiting patients (Current: 23 Nov 2006) - aprepitant,cyclophosphamide,dexamethasone,granisetron hydrochloride
Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - fentanyl citrate,hydromorphone,ropivacaine hydrochloride
TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary - This study is currently recruiting patients (Current: 23 Nov 2006) - oxaliplatin,docetaxel,bevacizumab
Chemosensitivity Assays in Predicting Response to Chemotherapy in Patients With Persistent, Refractory, or Recurrent Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,cisplatin,doxorubicin HCl liposome,gemcitabine hydrochloride,paclitaxel,topotecan hydrochloride
Screening for Ovarian Cancer in Participants With a Genetic Risk for Developing Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
PXD101 in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - PXD101
Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - docetaxel,phenoxodiol
Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,talabostat mesylate,temozolomide
Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Risk-Reducing Surgery to Remove Both Ovaries - This study is currently recruiting patients (Current: 23 Nov 2006) - zoledronate
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen - This study is currently recruiting patients (Current: 23 Nov 2006) - tamoxifen citrate
Doxil and Gemcitabine in Recurrent Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - liposomal doxorubicin and gemcitabine
Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy - This study has been completed (Current: 23 Nov 2006) - Hycamtin,Gemcitabine
Oxaliplatin and Topotecan in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - oxaliplatin,topotecan hydrochloride
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - lapatinib,paclitaxel (albumin-stabilized nanoparticle formulation)
Cisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - Topotecan,Cisplatin,Paclitaxel
Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies - This study is currently recruiting patients (Current: 23 Nov 2006) - pemetrexed,topotecan
Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - topotecan,Paraplatin
Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients - This study is currently recruiting patients (Current: 23 Nov 2006) - lapatinib (GW572016),Carboplatin,Paclitaxel
Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - lapatinib
Topotecan and Gefitinib (Iressa) for Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - Topotecan and Iressa
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy - This study is currently recruiting patients (Current: 23 Nov 2006) - MORAb-003
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers - This study is currently recruiting patients (Current: 23 Nov 2006) - 852A
Zoledronate in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant - This study is currently recruiting patients (Current: 23 Nov 2006) - calcium carbonate,calcium citrate,calcium glucarate,calcium gluconate,cholecalciferol,zoledronate
Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - Paclitaxel,Carboplatin
Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study - This study is currently recruiting patients (Current: 23 Nov 2006)
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - moxifloxacin hydrochloride
A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - MORAb-009
MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin Vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - liposomal doxorubicin,carboplatin,paclitaxel
Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - AVE0005 (VEGF Trap)
Blood Test for Ovarian Cancer Associated Antibodies (CAAb) - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,paclitaxel
E7389 in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - E7389
3-AP and External-Beam Radiation Therapy With or Without Cisplatin in Treating Patients With Gynecologic Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - 3-AP,cisplatin
Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
A Phase I Study of ECO-4601 in Patients With Advanced Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - ECO-4601
Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics - This study is no longer recruiting patients (Current: 23 Nov 2006)
Phase II Study of Weekly Topotecan With Bevacizumab in Platinum Resistant Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers - This study is currently recruiting patients (Current: 23 Nov 2006) - bevacizumab and topotecan
Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-Resistant Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - NOV-002
AFP464 in Treating Patients With Advanced Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - AFP464
Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma - This study is currently recruiting patients (Current: 23 Nov 2006)
Phase I Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Recurrent Platinum Sensitive Ovarian Cancer. - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Anti-CD137
Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,paclitaxel,pegfilgrastim
Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - capecitabine,docetaxel
AZD2171 in Treating Young Patients With Refractory or Recurrent Solid Tumors or Acute Myeloid Leukemia - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - AZD2171
Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant - This study is currently recruiting patients (Current: 23 Nov 2006) - methotrexate,methylprednisolone,prednisone
Denileukin Diftitox in Treating Patients With Advanced Refractory Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - denileukin diftitox
Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant - This study is currently recruiting patients (Current: 23 Nov 2006)
852A in Treating Patients With Refractory Metastatic Breast Cancer, Ovarian Cancer, Endometrial Cancer, or Cervical Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - 852A
Validation of a Score of Predictive Factors for Complete Resection in Platinum-Sensitive Recurrent Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - carboplatin,gemcitabine hydrochloride
BIBF 1120 in Treating Patients With Relapsed Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - VEGF inhibitor BIBF 1120
Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - MAGE-A1, Her-2/neu, FBP peptides ovarian cancer vaccine,carboplatin,incomplete Freund's adjuvant,paclitaxel,tetanus toxoid helper peptide
Monoclonal Antibody MORAb-009 in Treating Patients With Recurrent Advanced Tumors That Express Mesothelin - This study is currently recruiting patients (Current: 23 Nov 2006) - anti-mesothelin monoclonal antibody MORAb-009
Safety and Efficacy Study of the Trifunctional Antibody Catumaxomab to Treat Ovarian Cancer in Women After a Complete Response to Chemotherapy - This study is currently recruiting patients (Current: 23 Nov 2006) - catumaxomab
A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing - This study is currently recruiting patients (Current: 23 Nov 2006) - Cyclophosphamide
OVATURE (OVArian TUmor REsponse) Study - This study is currently recruiting patients (Current: 23 Nov 2006) - phenoxodiol (drug),carboplatin (drug)
Sunitinib in Treating Patients With Advanced or Metastatic Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - sunitinib malate
VEGF Trap in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma - This study is currently recruiting patients (Current: 23 Nov 2006) - VEGF Trap
Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - Sorafenib,Paclitaxel,Carboplatin
Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill") - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - enzastaurin,carboplatin,paclitaxel,placebo
Cyclophosphamide and Fludarabine Followed By White Blood Cell Infusion and High-Dose Aldesleukin in Treating Patients With Metastatic Cancer That Overexpresses p53 - This study is currently recruiting patients (Current: 23 Nov 2006) - aldesleukin,cyclophosphamide,filgrastim,fludarabine phosphate,therapeutic autologous lymphocytes
Safety and Efficacy Study of Panzem Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - Panzem Nanocrystal Colloidal Dispersion (NCD)
Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - carboplatin,paclitaxel
Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours - This study is no longer recruiting patients (Current: 23 Nov 2006) - Pegylated Liposomal Doxorubicin and Carboplatin

Drugs used in Clinical Trials for Ovarian Cancer

The format for each of the following is:

The drug,
followed by the name of the trial,
followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.

ClinicalTrials.gov has listed the following drugs in trials for Ovarian Cancer: